MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Current Assets came in at $91.8 million in Q4 2025, down 25.71% YoY from $123.5 million in Q4 2024, and up 168.51% on a QoQ basis from $34.2 million in Q3 2025.
MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Current Assets data on file, last reported at $91.8 million in Q4 2025.
- Quarterly Current Assets fell 25.71% year-over-year to $91.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.8 million (down 25.71% YoY) and the FY2025 annual result came in at $91.8 million, down 25.71% from the prior year.
- Current Assets improved to $91.8 million in Q4 2025, from $34.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $230.1 million in Q1 2021 to a low of $34.2 million in Q3 2025.
- A 5-year average of $132.9 million and a median of $141.0 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets jumped 37.1% — and 2025, when it tumbled 75.42%.
- Tracing MGTX's Current Assets over 5 years: stood at $183.2 million in 2021, then fell by 15.77% to $154.3 million in 2022, then increased by 3.42% to $159.6 million in 2023, then retreated by 22.62% to $123.5 million in 2024, then decreased by 25.71% to $91.8 million in 2025.
- The last three Current Assets figures came in at $91.8 million (Q4 2025), $34.2 million (Q3 2025), and $47.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 91.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.76 Mn |
| Sep 30, 2025 | 34.17 Mn |
| Jun 30, 2025 | 47.08 Mn |
| Mar 31, 2025 | 79.89 Mn |
| Dec 31, 2024 | 123.52 Mn |
| Sep 30, 2024 | 139.05 Mn |
| Jun 30, 2024 | 110.77 Mn |
| Mar 31, 2024 | 149.30 Mn |
| Dec 31, 2023 | 159.62 Mn |
| Sep 30, 2023 | 103.53 Mn |
| Jun 30, 2023 | 143.14 Mn |
| Mar 31, 2023 | 121.48 Mn |
| Dec 31, 2022 | 154.34 Mn |
| Sep 30, 2022 | 155.04 Mn |
| Jun 30, 2022 | 104.41 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 183.24 Mn |
| Sep 30, 2021 | 176.93 Mn |
| Jun 30, 2021 | 207.04 Mn |
| Mar 31, 2021 | 230.13 Mn |